The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Danilova N.V.

Lomonosov Moscow State University

Mikhailov I.A.

Center for Expertise and Quality Control of Medical Care;
Lomonosov Moscow State University

Oleynikova N.A.

Lomonosov Moscow State University

Polushkina T.V.

Lomonosov Moscow State University

Chayka A.V.

Herzen Moscow Oncology Research Institute — Branch Campus of the National Medical Radiology Research Center

Khomyakov V.M.

Herzen Moscow Oncology Research Institute — Branch Campus of the National Medical Radiology Research Center

Kakotkin V.V.

Lomonosov Moscow State University

Yudin M.Yu.

Separate subdivision «SM-Medica» of «SM-Clinic», LLC

Persistence of Epstein—Barr virus antigens in gastric cancer: characteristic of inflammatory cellular reactions in tumor

Authors:

Danilova N.V., Mikhailov I.A., Oleynikova N.A., Polushkina T.V., Chayka A.V., Khomyakov V.M., Kakotkin V.V., Yudin M.Yu.

More about the authors

Read: 2748 times


To cite this article:

Danilova NV, Mikhailov IA, Oleynikova NA, et al. . Persistence of Epstein—Barr virus antigens in gastric cancer: characteristic of inflammatory cellular reactions in tumor. Russian Journal of Archive of Pathology. 2021;83(1):18‑24. (In Russ.)
https://doi.org/10.17116/patol20218301118

Recommended articles:
Claudin-18.2 and gastric cancer: from physiology to carcinogenesis. Russian Journal of Archive of Pathology. 2024;(6):92-99
The phenomenon of tumor budding in gastric cancer. Russian Journal of Archive of Pathology. 2025;(2):79-87
Pancreaticoduodenectomy combined with multivisceral rese­ctions. Piro­gov Russian Journal of Surgery. 2024;(11):77-83
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139

References:

  1. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4(10):757-768.  https://doi.org/10.1038/nrc1452
  2. The Cancer Genome Atlas (TCGA). Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517): 202-209.  https://doi.org/10.1038/nature13480
  3. Camargo MC, Kim W-H, Chiaravalli AM, Kim K-M, Corvalan AH, Matsuo K, Yu J, Sung JJY, Herrera-Goepfert R, Meneses-Gonzalez F, Kijima Y, Natsugoe S, Liao LM, Lissowska J, Kim S, Hu N, Gonzalez CA, Yatabe Y, Koriyama C, Hewitt SM, Akiba S, Gulley ML, Taylor PR, Rabkin CS. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. 2014;63(2):236-243.  https://doi.org/10.1136/gutjnl-2013-304531
  4. Danilova NV, Mikhailov IA, Oleynikova NA, Malkov PG. Expression of LMP-1 protein in tumor cells and glandular epithelium of the peritumoral tissue in gastric cancer. Arkhiv patologii/Archive of Pathology. 2019;81(6):24-33. (In Russ.). https://doi.org/10.17116/patol20198106124
  5. Moss DJ, Burrows SR, Castelino DJ, Kane RG, Pope JH, Rickinson AB, Alpers MP, Heywood PF. A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea. Int J cancer. 1983;31(6): 727-732.  https://doi.org/10.1002/ijc.2910310609
  6. Whittle HC, Brown J, Marsh K, Greenwood BM, Seidelin P, Tighe H, Wedderburn L. T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature. 1984;312(5993):449-450.  https://doi.org/10.1038/312449a0
  7. Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol. 2007;25:587-617.  https://doi.org/10.1146/annurev.immunol.25.022106.141553
  8. Ma J, Li J, Hao Y, Nie Y, Li Z, Qian M, Liang Q, Yu J, Zeng M, Wu K. Differentiated tumor immune microenvironment of Epstein-Barr virus-associated and negative gastric cancer: implication in prognosis and immunotherapy. Oncotarget. 2017;8(40):67094-67103. https://doi.org/10.18632/oncotarget.17945
  9. Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada M V, Gonzalez-Ericsson PI, et al. Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the host immune response, TILs in invas. Adv Anat Pathol. 2017;24(5):235-251. 
  10. Münz C. Epstein Barr virus. vol. 1. One herpes virus: many diseases. Springer: Zürich; 2015. https://doi.org/10.1007/978-3-319-22822-8

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.